These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24554716)

  • 1. Growth differentiation factor (GDF)-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation.
    Xu XY; Nie Y; Wang FF; Bai Y; Lv ZZ; Zhang YY; Li ZJ; Gao W
    J Biol Chem; 2014 Apr; 289(14):10084-94. PubMed ID: 24554716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy.
    Li Y; Zhang H; Liao W; Song Y; Ma X; Chen C; Lu Z; Li Z; Zhang Y
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1941-51. PubMed ID: 21856923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
    Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
    Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between growth differentiation factor 15 and left ventricular hypertrophy in hypertensive patients and healthy adults.
    Kou H; Jin X; Gao D; Ma R; Dong X; Wei J; Wang X
    Clin Exp Hypertens; 2018; 40(1):8-15. PubMed ID: 29035099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex.
    Xie B; Tang W; Wen S; Chen F; Yang C; Wang M; Yang Y; Liang W
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.
    Deng L; Boujdir M; Tremontano A; Pincus MR; El-Sherif N
    Ann Clin Lab Sci; 2009; 39(4):351-60. PubMed ID: 19880762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of adrenergic receptor system in canine left ventricular hypertrophy].
    Shida M
    Kokyu To Junkan; 1989 Mar; 37(3):321-7. PubMed ID: 2525269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation.
    Tanner MA; Thomas TP; Grisanti LA
    J Mol Cell Cardiol; 2019 Nov; 136():1-14. PubMed ID: 31473246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
    Zeng SY; Chen X; Chen SR; Li Q; Wang YH; Zou J; Cao WW; Luo JN; Gao H; Liu PQ
    Can J Cardiol; 2013 Oct; 29(10):1310-9. PubMed ID: 23850346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells.
    Long CS; Ordahl CP; Simpson PC
    J Clin Invest; 1989 Mar; 83(3):1078-82. PubMed ID: 2537847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation of ErbB receptors by leptin in the cardiovascular system: mechanisms, consequences and target for therapy.
    Bełtowski J; Jazmroz-Wiśniewska A
    Curr Pharm Des; 2014; 20(4):616-24. PubMed ID: 23688012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts.
    Hanatani S; Izumiya Y; Takashio S; Kojima S; Yamamuro M; Araki S; Rokutanda T; Tsujita K; Yamamoto E; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H
    Heart Vessels; 2014 Mar; 29(2):231-7. PubMed ID: 23525862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hypoxia differentially regulates alpha 1-adrenergic receptor subtype mRNAs and inhibits alpha 1-adrenergic receptor-stimulated cardiac hypertrophy and signaling.
    Li HT; Long CS; Rokosh DG; Honbo NY; Karliner JS
    Circulation; 1995 Aug; 92(4):918-25. PubMed ID: 7641375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.
    Lok SI; Winkens B; Goldschmeding R; van Geffen AJ; Nous FM; van Kuik J; van der Weide P; Klöpping C; Kirkels JH; Lahpor JR; Doevendans PA; de Jonge N; de Weger RA
    Eur J Heart Fail; 2012 Nov; 14(11):1249-56. PubMed ID: 22843564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.
    Correa MV; Nolly MB; Caldiz CI; de Cingolani GE; Cingolani HE; Ennis IL
    Pflugers Arch; 2014 Sep; 466(9):1819-30. PubMed ID: 24327206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes.
    Zheng JS; Boluyt MO; Long X; O'Neill L; Lakatta EG; Crow MT
    Circ Res; 1996 Apr; 78(4):525-35. PubMed ID: 8635209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
    Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In brown adipocytes, adrenergically induced β₁-/β₃-(Gs)-, α₂-(Gi)- and α₁-(Gq)-signalling to Erk1/2 activation is not mediated via EGF receptor transactivation.
    Wang Y; Fälting JM; Mattsson CL; Holmström TE; Nedergaard J
    Exp Cell Res; 2013 Oct; 319(17):2718-27. PubMed ID: 23948306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells.
    Piiper A; Dikic I; Lutz MP; Leser J; Kronenberger B; Elez R; Cramer H; Müller-Esterl W; Zeuzem S
    J Biol Chem; 2002 Nov; 277(46):43623-30. PubMed ID: 12218049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.